Intravenous products: Infection Control Today report “Two physicians will discuss their research findings on SwabCap® during podium presentations at the upcoming annual meeting of the Association for Vascular Access (AVA).
SwabCap allowed for significant reductions of central-line-associated bloodstream infections (CLABSIs) at a meaningful cross-section of medical facilities, according to clinical research to be presented by Gregory Schears, MD, of Rochester, Minn. Also presenting research in a podium talk will be Eddie Simpser, MD, FAAP, executive vice president and chief medical officer of St. Mary’s Healthcare System for Children in Bayside, N.Y.
In addition to the doctors’ talks, two scientific poster presentations at the conference will outline how the disinfection cap allowed for dramatic reductions in CLABSI rates. One of the posters is from Simpser’s facility. The other is from St. Francis Hospital, in Columbus, Ga. Schears’ presentation will summarize a multi-site study in 12 hospitals that trialed the disinfection cap. Preliminary results showed SwabCap allowed for an average CLABSI rate reduction of 53 percent. Simpser will report data from a St. Mary’s Hospital for Children initiative to reduce CLABSIs. The combination of SwabCap, a foam disc and IV line scrubbing sharply reduced the hospital’s CLABSI rate.